InvestorsHub Logo
Followers 0
Posts 73
Boards Moderated 0
Alias Born 07/10/2017

Re: None

Monday, 04/09/2018 12:50:07 AM

Monday, April 09, 2018 12:50:07 AM

Post# of 379
This article appears to state a US acquisition and NASDQ listing this year.

https://www.shuidichou.com/content/healthynews/561a9c3c-a357-4103-b841-1d314d0effed


About Tongren Equity Allocation:


US Nasdaq listed company will be acquired one year later (100% shareholding) Guizhou Tongren Zhongkang Biotechnology Co., Ltd. (total share capital: RMB 1 billion RMB). Its equity allocation is as follows:








NASDAQ Listed Company Public Management Certificate

Guizhou Zhongjing Times Enterprise Management Co., Ltd. Introduction:



Guizhou Beijing Times Enterprise Management Co., Ltd. was established in September 2017 with a registered capital of 50 million yuan, under the Beijing Times Investment Holdings (Shenzhen) Co., Ltd. subsidiary.



Guizhou Zhongjing holds a 20% stake in “ Guizhou Tongren Zhongkang Biotechnology Co., Ltd. ”. Inspirational and Zhongjian Biotech carry out research and application of biotechnology . Through exchanges and cooperation with well-known medical research institutions at home and abroad, they are committed to the medical industry. The development and construction of tourism and convalescence industry, bio-health technology development, etc. provide the most suitable individualized health management solutions for high-end customers nationwide.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.